HUM241011P300000
- 57.01
- +0.41+0.72%
Humana Newsroom
Stephens & Co. Reiterates Equal-Weight on Humana, Maintains $250 Price Target
Humana Raised to Outperform From Market Perform by Bernstein
Humana Ends Selloff as Bernstein Upgrades on Attractive Entry Point
Humana Is Maintained at Outperform by RBC Capital
Humana Analyst Ratings
RBC Capital Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $265
RBC Cuts Price Target on Humana to $265 From $400, Keeps Outperform Rating
RBC Capital Reaffirms Their Buy Rating on Humana (HUM)
Cognizant's Revenue Outlook: A Hold Rating Amidst Humana's Anticipated Spending Changes
Bernstein Upgrades Humana(HUM.US) to Buy Rating, Cuts Target Price to $308
Bernstein lowers Humana's target price to $308.
Bernstein Upgrades Humana to Outperform From Market Perform, Adjusts Price Target to $308 From $405
Wells Fargo Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $387
TD Cowen Downgrades Humana(HUM.US) to Hold Rating, Cuts Target Price to $261
Jefferies Downgrades Humana(HUM.US) to Hold Rating, Cuts Target Price to $253
Hold Rating on Humana Amid Stars Rating Appeal Uncertainty and Growth Challenges
UBS Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $250
Humana Is Maintained at Neutral by UBS
Humana Analyst Ratings
A Quick Look at Today's Ratings for Humana(HUM.US), With a Forecast Between $250 to $364